Asia Pacific Histology And Cytology Market Size & Outlook
Related Markets
Asia Pacific histology and cytology market highlights
- The Asia Pacific histology and cytology market generated a revenue of USD 4,396.2 million in 2024.
- The market is expected to grow at a CAGR of 16.3% from 2025 to 2030.
- In terms of segment, cytology was the largest revenue generating type in 2024.
- Cytology is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 4,396.2 million |
| Market revenue in 2030 | USD 10,890.6 million |
| Growth rate | 16.3% (CAGR from 2025 to 2030) |
| Largest segment | Cytology |
| Fastest growing segment | Cytology |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Histology, Cytology |
| Key market players worldwide | Hologic Inc, BD, Abbott Laboratories, Merck KGaA, Roche Holding AG, Thermo Fisher Scientific Inc, Becton Dickinson & Co, Danaher Corp, Sysmex Corp, Koninklijke Philips NV |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.8% of the global histology and cytology market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,890.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Histology And Cytology Market Scope
Histology And Cytology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Asia Pacific histology and cytology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to histology and cytology market will help companies and investors design strategic landscapes.
Cytology was the largest segment with a revenue share of 71.98% in 2024. Horizon Databook has segmented the Asia Pacific histology and cytology market based on histology, cytology covering the revenue growth of each sub-segment from 2018 to 2030.
Due to unhealthy lifestyle, large geriatric population, and socioeconomic conditions, there is high incidence of cancer across the Asia Pacific region. Hence, larger target population, increase in awareness about cancer screening, and investment of multinational companies in this region are some of the factors expected to drive the market during the forecast period.
Japan, China, India, Singapore, and Australia are major contributing countries in the region. Initiatives from WHO, especially in the Southeast Asian (Bangladesh, Bhutan, Korea, India, Indonesia, and Thailand) region, have raised awareness and created opportunities to treat several cancers in these regions. Cervical cancer is the second most common type of cancer in Southeast Asian women. There are significant number of cervical cancer patients in Thailand, with approximately 6,000 cases diagnosed every year. Government health providers have initiated National Cancer Control Program, a campaign to raise disease awareness.
Increasing initiatives by the government and private bodies are expected to create significant growth opportunities. However, low coverage for cervical cancer screening may hamper the adoption of products & services in the country. Lack of proper financial support by public and government funding in lower- to middle-income Asian countries, such as Bhutan and Sri Lanka, and minimal coverage are likely to hinder growth of the histology and cytology market in the region.
Reasons to subscribe to Asia Pacific histology and cytology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific histology and cytology market databook
-
Our clientele includes a mix of histology and cytology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific histology and cytology market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific histology and cytology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific histology and cytology market size, by country, 2018-2030 (US$M)
Asia Pacific Histology And Cytology Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
